Avadel Pharmaceuticals (AVDL) PT Lowered to $16 at Needham & Company But Remaining Optimistic of an Approval
Tweet Send to a Friend
Needham & Company analyst Ami Fadia lowered the price target on Avadel Pharmaceuticals (NASDAQ: AVDL) to $16.00 (from $17.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
